14 Sep. 2023
In Alliance with B.L.HUA, Orient PHARMA’s New ADHD Durg Enters Thailand to Expand Southeast Asia Market
MORE
27 Jul. 2023
OEP’s Cytotoxic Oncology Injection Plant Completed US FDA Inspection
MORE
26 Jun. 2023
OEP Statement：Regarding the Weight Management Prescription Drug from Unknown Sources on the Internet
MORE
29 Mar. 2023
OEP Enters into a License and Distribution Agreement with OncoVent for Oregovomab, an Advanced Primary Ovarian Cancer Immunotherapy Drug Candidate
MORE
08 Nov. 2022
Preventive Voluntary Recall for Ectrin Capsule 300mg (Update)
MORE
25 Oct. 2022
Orient EuroPharma Introduces Novel injectable treatments Manufactured by Chiesi for the Treatment of Rare Diseases, Offering New Therapeutic Options of Enzyme Replacement Therapy to Patients in Taiwan and Southeast Asia Markets
MORE
22 Sep. 2022
Taiwan Is Facing Obesity Crisis; the Latest Mechanistically Modified Oral Obesity Drug Is Available for Prescription
MORE
04 Aug. 2022
Cumlaude Lab, the Spain Leading Women Intimate Care Products Are Now Availabe in Taiwan
MORE
12 Jul. 2022
OEP Enters into a Strategic Partnership with Overland ADCT BioPharma to Address the Unmet Needs of Lymphoma Patients in Taiwan and Singapore
MORE
09 May. 2022
OEP introduces the latest long-acting injection approved for the treatment of schizophrenia in Europe and acquires Taiwan and Hong Kong distribution rights to expand psychiatry product portfolio
MORE
